CASSANDRA PRONTI: Open Payments
NPI 1336791896 · HERKIMER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,108 in 44 payments from 25 companies in 2025. Trend: 2023 $2,457 · 2024 $2,540 · 2025 $1,108
Food & beverage: $926Education: $182
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $104 |
| SEAGEN INC. | 1 | $99 |
| SANOFI-AVENTIS U.S. LLC | 1 | $83 |
| Daiichi Sankyo Inc. | 3 | $70 |
| Regeneron Healthcare Solutions, Inc. | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| PFIZER INC. | 3 | $59 |
| Astellas Pharma US Inc | 3 | $56 |
| GENZYME CORPORATION | 2 | $53 |
| Ipsen Biopharmaceuticals, Inc | 2 | $52 |
Products named: SARCLISA, LIBTAYO, Enhertu, Onivyde, Nubeqa, XTANDI, Vyloy, REBLOZYL.
Industry payments across NY — which companies pay providers there.
